Sign in

CIK 0001659617

  • Non-accelerated filer
  • Smaller reporting company

Moleculin Biotech, Inc.

Sign in to watch
Ticker
MBRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474671997
Phone
+1 713-300-5160
Business address
5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-11-12 CANNON MICHAEL D Director Grant or award · Stock Options (right to buy) +150,000 165,336
2024-11-04 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +10,000 15,336
2023-05-25 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +15,000 80,001
2022-06-20 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +23,333 50,001
2022-06-20 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +15,000 65,001
2021-06-07 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +10,000 26,668
2020-06-15 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +15,000 100,000
2019-07-11 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +35,000 120,000
2019-05-22 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +15,000 85,000
2018-06-06 CANNON MICHAEL D Director Grant or award · Stock option (right to buy) +35,000 70,000
2017-07-24 CANNON MICHAEL D Director Grant or award · Option to purchase common stock +15,000 35,000
2016-09-23 CANNON MICHAEL D Director Grant or award · Option to purchase common stock +20,000 20,000

Page 1 of 1 · 12 trades